Alexandria, VA — December 1, 2025 — The National Home Infusion Association (NHIA) today announced growing bipartisan momentum for the Preserving Patient Access to Home Infusion Act, with ten new cosponsors signing onto the bill in the wake of NHIA’s Advocacy in Action Day.

Immediately prior to NHIA’s annual member visits to Capitol Hill, Reps. Jimmy Panetta (D-CA) and Paul Tonko (D-NY) joined the legislation in anticipation of meetings with home infusion providers, suppliers, and patients. Since the event, Reps. Danny Davis (D-IL), Madeleine Dean (D-PA), Ted Lieu (D-CA), Doris Matsui (D-CA), Blake Moore (R-UT), Burgess Owens (R-UT), Greg Stanton (D-AZ), and Darren Soto (D-FL) have also signed on as cosponsors, reflecting the growing recognition that Medicare’s current home infusion benefit is failing seniors.

“Home infusion is a proven, patient-preferred model that helps keep people out of the hospital while lowering total health care costs,” said Connie Sullivan, BSPharm, President and CEO of NHIA. “The fact that ten Members of Congress have joined this bill in just a few weeks is a direct reflection of the stories our members and their patients shared on Advocacy in Action Day. Their voices are driving this momentum.”

On November 5, NHIA members held more than 130 meetings with lawmakers and staff from over 25 states to highlight the Medicare home infusion coverage gap and the need to modernize the benefit. Participants emphasized how the legislation would better recognize the pharmacy and clinical services that make home infusion possible and expand access to IV anti-infective treatments for as many as one million Medicare beneficiaries each year.

“The power behind this effort is the real-world experience our members bring to Capitol Hill,” Sullivan added. “They see every day how much better patients do when they can receive care at home, and they are making that case directly to policymakers. We are encouraged by this growing support and will continue working with Congress to ensure Medicare beneficiaries have timely access to home infusion services.”

The Preserving Patient Access to Home Infusion Act would modernize Medicare’s home infusion therapy benefit by closing existing coverage gaps and recognizing pharmacy professional services essential to the safe delivery of care in the home as well as expanding care for Medicare beneficiaries who require IV anti-infective treatments. By aligning Medicare policy with the commercial insurance model, the legislation would ensure patients have access to home infusion services when clinically appropriate and reduce overall health care costs by allowing more patients to receive therapy in the most appropriate and cost-effective setting.

###

NHIA is a trade association representing companies that provide infusion therapy to patients in their homes and companies that manufacture and supply infusion-related products and services. Infusion therapy involves supplying and administering patient-specific sterile medications, and coordinating a range of pharmacy, nursing, and other clinical services for delivering care to patients in the home setting. For more information, visit www.nhia.org.